Clinical trials play a critical role in advancing dermatologic care and expanding treatment options. This session introduces learners to the fundamentals of clinical research, including trial phases, regulatory considerations, and site responsibilities. Faculty will outline practical steps for getting involved, from identifying opportunities to participating as a sub-investigator or study coordinator. Attendees will gain insight into the benefits, challenges, and ethical considerations of clinical trial participation, along with strategies to integrate research into clinical practice.

This session provides NPs and PAs with an updated understanding of vitiligo as an immune-mediated disease. Attendees will explore key inflammatory pathways driving depigmentation and how they inform emerging treatment strategies. Faculty will review repigmentation approaches, including topical, systemic, and procedural options. Emphasis will be placed on patient counseling, setting expectations, and supporting long-term disease management.

This interactive panel session brings together expert faculty to address key questions and real-world challenges in clinical practice. Through audience-driven discussion, attendees will gain practical insights, diverse perspectives, and evidence-based guidance on complex topics. Emphasis will be placed on open dialogue, allowing learners to engage directly with experts and apply takeaways to everyday practice.

Cutaneous manifestations often provide early clues to underlying gastrointestinal disease. This session equips NPs and PAs to recognize dermatologic signs associated with IBD, celiac disease, and other GI disorders. Faculty will discuss diagnostic considerations, pathophysiologic links, and treatment implications. Attendees will learn how to coordinate care across specialties to improve patient outcomes.

Dermatologic diseases frequently involve the eyes, requiring timely recognition and interdisciplinary care. This session reviews common and high-risk ocular manifestations linked to inflammatory and autoimmune skin conditions. NPs and PAs will learn when to initiate treatment and when to refer to ophthalmology. Practical strategies for collaborative care and preventing vision-threatening complications will be emphasized.

Acne management requires age-specific considerations and a comprehensive understanding of systemic therapies. This session reviews treatment strategies for adolescents through older adults, including hormonal therapies, antibiotics, and isotretinoin. Faculty will address safety considerations, monitoring, and patient adherence. NPs and PAs will gain tools to individualize care across diverse patient populations.

This interactive panel session brings together expert faculty to address key questions and real-world challenges in clinical practice. Through audience-driven discussion, attendees will gain practical insights, diverse perspectives, and evidence-based guidance on complex topics. Emphasis will be placed on open dialogue, allowing learners to engage directly with experts and apply takeaways to everyday practice.

Hidradenitis suppurativa is a chronic inflammatory skin disease that often goes unrecognized, leading to delayed diagnosis and significant patient burden. This session reviews the pathogenesis of HS, strategies for early identification, and approaches to individualized treatment. Faculty will discuss current biologic therapies alongside emerging data on oral JAK inhibitors and their potential role in disease management. Attendees will gain practical guidance on treatment selection, sequencing, and optimizing long-term outcomes for patients with HS. Learning Objectives Recognize the clinical presentations, high-risk features, and consequences of delayed diagnosis in HS to support timely, evidence-based intervention and prevent disease progression Explain the role of the JAK/STAT signaling pathway in HS pathogenesis and describe the mechanisms by which oral JAK1 inhibitors may modulate disease activity Evaluate the efficacy and safety data for biologic therapies and oral JAK inhibitors in HS to inform individualized treatment selection Apply evidence-based treatment strategies for patients with moderate-to-severe HS, incorporating patient preferences, comorbidities, prior treatment response, and practical considerations into shared decision-making This activity is supported through an independent educational grant from Incyte Corporation.

Sponsored by Eli Lilly and Company.

These highly interactive educational sessions offer a comprehensive and practical look into a diverse array of dermatologic conditions. With a focus on translating current research into practical, real-world applications, these sessions will help you to effectively integrate the latest advances in dermatologic care into clinical practice, enhancing your professional skills and improving patient outcomes. Both seasoned and early-career dermatology professionals will benefit from these educational grant–supported sessions. Applications for commercial support from healthcare-related industries are pending. Commercial support will be acknowledged as it is received.

Early identification of psoriatic arthritis (PsA) is critical to preventing irreversible joint damage. This session trains NPs and PAs to recognize subtle clinical signs and differentiate PsA from other musculoskeletal conditions. Faculty will outline efficient screening tools and evidence-based treatment pathways. Emphasis will be placed on timely referral and coordinated care.

Rosacea presents with diverse phenotypes that require tailored treatment strategies. This session reviews subtype classification, underlying mechanisms, and triggers. NPs and PAs will learn how to match therapies—including topicals, lasers, and systemic agents—to specific clinical presentations. Practical guidance on long-term management and patient education will be provided.

This interactive panel session brings together expert faculty to address key questions and real-world challenges in clinical practice. Through audience-driven discussion, attendees will gain practical insights, diverse perspectives, and evidence-based guidance on complex topics. Emphasis will be placed on open dialogue, allowing learners to engage directly with experts and apply takeaways to everyday practice.

These highly interactive educational sessions offer a comprehensive and practical look into a diverse array of dermatologic conditions. With a focus on translating current research into practical, real-world applications, these sessions will help you to effectively integrate the latest advances in dermatologic care into clinical practice, enhancing your professional skills and improving patient outcomes. Both seasoned and early-career dermatology professionals will benefit from these educational grant–supported sessions. Applications for commercial support from healthcare-related industries are pending. Commercial support will be acknowledged as it is received.

Chronic inflammatory diseases increase the risk of cardiovascular and metabolic complications. This session explores shared inflammatory pathways and their systemic impact. NPs and PAs will learn how to assess risk factors, implement screening protocols, and integrate preventive strategies into routine care. The importance of interdisciplinary management will be highlighted.

Alopecia areata is characterized by an unpredictable course with frequent relapse. This session reviews strategies for maintaining disease control and minimizing recurrence. Faculty will discuss long-term use of emerging therapies, including JAK inhibitors, and how to monitor safety. NPs and PAs will also learn how to address the psychosocial burden of chronic hair loss.

This interactive panel session brings together expert faculty to address key questions and real-world challenges in clinical practice. Through audience-driven discussion, attendees will gain practical insights, diverse perspectives, and evidence-based guidance on complex topics. Emphasis will be placed on open dialogue, allowing learners to engage directly with experts and apply takeaways to everyday practice.

Sponsored by Amgen.

Pigmentary disorders present unique diagnostic and therapeutic challenges in patients with skin of color. This session reviews conditions such as melasma, post-inflammatory hyperpigmentation, and hypopigmentation disorders. Faculty will highlight evidence-based treatments and common pitfalls to avoid. Emphasis will be placed on culturally competent care and patient-centered communication.

Dermoscopy enhances diagnostic accuracy but requires skillful interpretation. This session advances NPs and PAs’ knowledge in recognizing complex dermoscopic patterns and distinguishing benign from malignant lesions. Faculty will review high-risk features and common diagnostic pitfalls. Attendees will gain confidence in integrating dermoscopy into clinical decision-making.

Hair and scalp disorders in patients of color require culturally informed approaches. This session explores how hairstyling practices influence conditions such as traction alopecia and scalp dermatitis. NPs and PAs will learn to provide respectful, personalized treatment recommendations. Strategies for building trust and improving adherence will be emphasized.

This interactive panel session brings together expert faculty to address key questions and real-world challenges in clinical practice. Through audience-driven discussion, attendees will gain practical insights, diverse perspectives, and evidence-based guidance on complex topics. Emphasis will be placed on open dialogue, allowing learners to engage directly with experts and apply takeaways to everyday practice.

Obesity is a common and often underrecognized comorbidity in patients with psoriasis that can influence disease severity, treatment response, and overall health outcomes. This session explores the shared inflammatory pathways linking psoriasis and obesity and highlights the importance of routine screening and patient-centered counseling. Attendees will gain practical strategies for incorporating evidence-based weight management approaches into dermatology practice. Through clinical examples and real-world applications, learners will be better equipped to deliver comprehensive care that addresses both skin disease and metabolic health. Learning Objectives • Assess the shared pathophysiologic mechanisms linking obesity and PsO and their impact on response to biologic therapies • Implement evidence-based screening strategies (eg, BMI, waist circumference) for obesity and overweight in patients with PsO • Evaluate available and emerging treatment strategies for PsO that also consider obesity and overweight to improve response and overall outcomes • Address cardiometabolic risk in patients with comorbid PsO and obesity, including diabetes, metabolic syndrome, and cardiovascular disease, through comprehensive, multidisciplinary care This activity is supported through an independent educational grant from Lilly USA, LLC.

Sponsored by Sanofi | Regeneron.

Ultrasound is an emerging tool in dermatologic diagnosis and disease monitoring. This session introduces NPs and PAs to its clinical applications, including evaluation of inflammatory and soft tissue conditions. Faculty will review image interpretation and practical limitations. Attendees will learn how to incorporate ultrasound into everyday practice.

Urticaria presents differently across age groups, requiring tailored evaluation and treatment. This session compares pediatric and adult presentations, including triggers and disease course. NPs and PAs will review diagnostic approaches and stepwise management strategies. Guidance on when to escalate care or refer will be provided.

Chronic pruritus is a complex and often multifactorial condition that can significantly impact quality of life. This session equips learners with a structured approach to evaluating persistent itch, including key history, physical exam findings, and appropriate diagnostic testing. Faculty will review common underlying etiologies and highlight when to consider systemic or neuropathic causes. Attendees will gain practical guidance on selecting targeted therapies, managing refractory cases, and improving patient outcomes through individualized care.

This interactive panel session brings together expert faculty to address key questions and real-world challenges in clinical practice. Through audience-driven discussion, attendees will gain practical insights, diverse perspectives, and evidence-based guidance on complex topics. Emphasis will be placed on open dialogue, allowing learners to engage directly with experts and apply takeaways to everyday practice.

These highly interactive educational sessions offer a comprehensive and practical look into a diverse array of dermatologic conditions. With a focus on translating current research into practical, real-world applications, these sessions will help you to effectively integrate the latest advances in dermatologic care into clinical practice, enhancing your professional skills and improving patient outcomes. Both seasoned and early-career dermatology professionals will benefit from these educational grant–supported sessions. Applications for commercial support from healthcare-related industries are pending. Commercial support will be acknowledged as it is received.

This interactive session challenges NPs and PAs with real-world, high-complexity cases. Faculty will guide discussion on treatment selection, comorbidities, and interdisciplinary care. The session emphasizes critical thinking and practical decision-making skills.

This interactive panel session brings together expert faculty to address key questions and real-world challenges in clinical practice. Through audience-driven discussion, attendees will gain practical insights, diverse perspectives, and evidence-based guidance on complex topics. Emphasis will be placed on open dialogue, allowing learners to engage directly with experts and apply takeaways to everyday practice.